Bangkok Dusit Medical Stock Return On Equity
| BDULFDelisted Stock | USD 0.73 0.00 0.00% |
Bangkok Dusit Medical fundamentals help investors to digest information that contributes to Bangkok Dusit's financial success or failures. It also enables traders to predict the movement of Bangkok Pink Sheet. The fundamental analysis module provides a way to measure Bangkok Dusit's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bangkok Dusit pink sheet.
Bangkok |
Bangkok Dusit Medical Company Return On Equity Analysis
Bangkok Dusit's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Bangkok Dusit Return On Equity | 0.15 |
Most of Bangkok Dusit's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bangkok Dusit Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Bangkok Dusit Medical has a Return On Equity of 0.1464. This is 100.61% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The return on equity for all United States stocks is 147.23% lower than that of the firm.
Bangkok Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bangkok Dusit's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bangkok Dusit could also be used in its relative valuation, which is a method of valuing Bangkok Dusit by comparing valuation metrics of similar companies.Bangkok Dusit is currently under evaluation in return on equity category among its peers.
Bangkok Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0739 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 13.03 B | |||
| Shares Owned By Institutions | 8.46 % | |||
| Price To Earning | 50.79 X | |||
| Price To Book | 4.91 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 74.45 B | |||
| Gross Profit | 24.99 B | |||
| EBITDA | 17.64 B | |||
| Net Income | 7.94 B | |||
| Cash And Equivalents | 16.66 B | |||
| Cash Per Share | 1.05 X | |||
| Total Debt | 12.5 B | |||
| Debt To Equity | 0.21 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 5.41 X | |||
| Cash Flow From Operations | 14.56 B | |||
| Earnings Per Share | 0.02 X | |||
| Number Of Employees | 45 | |||
| Beta | 0.43 | |||
| Market Capitalization | 13.53 B | |||
| Total Asset | 128.45 B | |||
| Retained Earnings | 28.38 B | |||
| Working Capital | (3.49 B) | |||
| Current Asset | 12.76 B | |||
| Current Liabilities | 16.25 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 128.45 B | |||
| Last Dividend Paid | 0.5 |
About Bangkok Dusit Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bangkok Dusit Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bangkok Dusit using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bangkok Dusit Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Bangkok Pink Sheet
If you are still planning to invest in Bangkok Dusit Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bangkok Dusit's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |